Principles and Reality of Proton Therapy Treatment Allocation

详细信息    查看全文

• 作者：Justin E. Bekelman ; MD^&lowast ; ; ^&dagger ; ; ^&Dagger ; ; ^{bekelman@uphs.upenn.edu" class="auth_mail} ; David A. Asch ; MD ; MBA^&Dagger ; ; ^§ ; ; Zelig Tochner ; MD^&lowast ; ; Joseph Friedberg ; MD^鈥?/sup> ; David J. Vaughn ; MD^¶ ; ; Ellen Rash ; MS ; BSN ; RN^&lowast ; ; Kevin Raksowski ; MD^# ; Stephen M. Hahn ; MD^&lowast ;
• 刊名：International Journal of Radiation Oncology*Biology*Physics
• 出版年：1 July 2014
• 年：2014
• 卷：89
• 期：3
• 页码：499-508
• 全文大小：795 K

文摘

To present the principles and rationale of the Proton Priority System (PROPS), a priority points framework that assigns higher scores to patients thought to more likely benefit from proton therapy, and the distribution of PROPS scores by patient characteristics

Methods and Materials

We performed multivariable logistic regression to evaluate the association between PROPS scores and receipt of proton therapy, adjusted for insurance status, gender, race, geography, and the domains that inform the PROPS score.

Results

Among 1529 adult patients considered for proton therapy prioritization during our Center's ramp-up phase of treatment availability, PROPS scores varied by age, diagnosis, site, and other PROPS domains. In adjusted analyses, receipt of proton therapy was lower for patients with non-Medicare relative to Medicare health insurance (commercial vs Medicare: adjusted odds ratio [OR] 0.47, 95% confidence interval [CI] 0.34-0.64; managed care vs Medicare: OR 0.40, 95% CI 0.28-0.56; Medicaid vs Medicare: OR 0.24, 95% CI 0.13-0.44). Proton Priority System score and age were not significantly associated with receipt of proton therapy.

Conclusions

The Proton Priority System is a rationally designed and transparent system for allocation of proton therapy slots based on the best available evidence and expert opinion. Because the actual allocation of treatment slots depends mostly on insurance status, payers may consider incorporating PROPS, or its underlying principles, into proton therapy coverage policies.